- Multi-Asset Strategist
Skip to main content
- Funds
- Insights
- Capabilities
- About Us
- My Account
United States, Institutional
Changechevron_rightThank you for your registration
You will shortly receive an email with your unique link to our preference center.
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional or accredited investors only.
The One Big Beautiful Bill Act (OBBBA) is now law. Considering the bill’s heft — almost 1,000 pages — the long-term economic and market implications are still being weighed and debated. I see two initial takeaways that allocators can incorporate into their investment decisions. First, I expect the Act to be a net positive for economic growth and company earnings over the next 12 months due to its pro-business stance. Second, the clear negative for markets is the postponement of meaningful spending cuts, which will put US debt on a trajectory toward 125% of GDP by 2034, according to the Congressional Budget Office — a level that could increase long-term US Treasury yields and weaken the US dollar further.
The Act reinstates and/or makes permanent changes that should benefit businesses and boost economic growth, including: 1) increasing the bonus depreciation rate for qualified property (e.g., certain machinery and equipment) from 40% to 100%; 2) providing an immediate ability to deduct R&D expenses; and 3) returning to a more generous EBITDA-based limit for interest deductibility on loans.
Combined, these and other changes will likely increase cash flow for companies and encourage investment spending. Independent estimates suggest these measures could boost growth in the medium term by as much as 0.7%, but as I explain below, we see potential for the effects to be felt sooner and to a greater degree.
Spending cuts, estimated at a net US$1.1 trillion and phased in over 10 years, are concentrated in Medicaid, Medicare, and SNAP (Supplemental Nutrition Assistance Plan), with most changes becoming effective after the US mid-term elections in 2026. Clean energy tax credits are also scheduled to sunset by the end of 2027.
While these cuts are designed to offset the cost of the tax breaks and other provisions, the Act is still expected to add US$3.4 trillion to the federal deficit over the next 10 years. Additionally, it is uncertain whether the spending cuts will ultimately be implemented. Legal challenges could delay implementation, and Congress could amend or repeal parts of the OBBBA before full implementation, especially if political control of the White House and Congress shifts. Similarly, some provisions set to expire could become permanent, also raising the deficit.
It is worth mentioning that the US is not alone in increasing government spending. As my colleague and I discuss in our latest Asset Allocation Outlook, Europe and Japan are loosening fiscal policy, which has implications for inflation and yields.
While passage of the Act on July 4 as planned likely avoided a market hiccup, I’m not sure it reduced policy uncertainty meaningfully, given that tariffs remain the biggest policy-driven risk for markets, as President Trump issues new threats to various countries and a new deadline of August 1 approaches. Still, risk assets seem to have become inured to tariff threats, assuming they will again be walked back or postponed.
As for the OBBBA, the market may be underappreciating the growth impulse the business-focused provisions of the legislation could deliver. Heretofore, the assumption has been that tariffs will hurt US growth and elevate inflation. But Wellington Macro Strategist Mike Medeiros thinks the new law could add up to a full percentage point in aggregate to GDP in 2025 and 2026 from the corporate side, offsetting the negative growth impact of tariffs. We are also hearing from our Global Industry Analysts about productivity gains from AI at the company level, which could also be a non-inflationary source of growth.
Deregulation efforts by the Trump administration could be another fillip to growth. For example, liquidity rules have hindered US banks’ efforts to lever their excess capital, constraining credit creation in the banking system and shifting activity to the nonbank financial system. Less restrictive capital rules could make it easier for banks to lend and further spur US growth.
If growth surprises to the upside, what about inflation? Growth-induced inflation is better than supply-shock-induced inflation and would be more likely to be tolerated by businesses and consumers. And as noted, improved productivity could be a limiting factor for inflation.
Bond markets may not be sufficiently pricing in the risks of stronger nominal US growth. This may translate into higher nominal bond yields.
Stronger growth may mean that rate cuts by the Federal Reserve are delayed. Expectations for two 25 bp rate cuts this year may not be met if nominal growth surprises to the upside.
The backdrop for US equity returns is more balanced in my view, with two-sided risks. On the downside, they may be vulnerable if higher-than-expected tariffs spark supply-induced inflation. On the upside, the incentives for greater business spending and deregulation could spur growth and offset the adverse effects of tariffs.
Keep watching the term premium on US 10-year Treasuries. Markets will signal displeasure with fiscal policy via the term premium (the extra yield investors expect for holding longer-term bonds over shorter-term bonds), which has been rising recently (Figure 1) and has done so in the past due to government spending concerns.
Figure 1
Expert
Related insights
Stagflation watch: Thoughts on tariffs, inflation, and Fed policy
Continue readingWeighing the economic winners and losers of the One Big Beautiful Bill Act
Continue readingFiscal versus tariffs: what wins out for Europe?
Continue readingHow China can offset the tariff shock
Continue readingWhat do tariffs mean for portfolios?
Continue readingEarly thoughts on historic hike in US tariffs
Continue readingCould “Liberation Day” trigger a shift in capital flows?
Continue readingBy
URL References
Related Insights
Stay up to date with the latest market insights and our point of view.
Thank you for your registration
You will shortly receive an email with your unique link to our preference center
Stagflation watch: Thoughts on tariffs, inflation, and Fed policy
US Macro Strategist Juhi Dhawan considers signs the US economy may be moving toward a toxic mix of slowing growth and rising inflation, creating challenges for the Fed and investors.
Weighing the economic winners and losers of the One Big Beautiful Bill Act
Macro Strategist Juhi Dhawan unpacks the impact of One Big Beautiful Bill Act, including its potential effect on economic growth, corporate earnings, and the US government deficit and debt.
Fiscal versus tariffs: what wins out for Europe?
Just as investors were starting to explore the potential for growth in Europe, Trump’s tariffs landed. To what extent is the case for Europe still intact?
How China can offset the tariff shock
Macro Strategist Johnny Yu details the approaches Beijing could take to offset the tariff shock, from fiscal strategies to potential retaliatory measures to concessions that Washington may welcome.
What do tariffs mean for portfolios?
Tariffs exceeded market expectations. Now what? Expect short-term volatility, identify concentrations and consider using sell-offs as an entry point to diversify across regions and styles, says Nanette Abuhoff Jacobson, Global Investment and Multi-Asset Strategist.
Early thoughts on historic hike in US tariffs
Macro Strategist Michael Medeiros explores the significant economic and market implications of the latest US tariffs, highlighting potential recession and inflation spikes, and the impact on global trade relations.
Could “Liberation Day” trigger a shift in capital flows?
John Butler discusses groundbreaking US tariffs, their impact on capital flows, and the changing investor perception of the US and Europe.
By
Shrinking the government footprint: Medicaid cuts and America’s economic health
Macro Strategist Juhi Dhawan looks at what changes to the mammoth US Medicaid program could mean for economic growth, employment, inflation, and financial markets.
Chart in Focus: how sustainable is Europe’s rally?
Is the recent rally in European equities sustainable? In this edition of our Chart in Focus series, we explore the potential path ahead.
Multiple authors
Shrinking the government footprint: Deregulation and the US economy
Macro Strategist Juhi Dhawan shares her view on the economic effects of the Trump administration’s efforts to slash red tape, including the impact on growth and inflation, as well as some of the potential drawbacks of this approach.
The US equity rotation: Where have all the good vibes gone?
After riding into 2025 on a wave of post-election euphoria, the US stock market has struggled to find its footing so far this year. Global Investment and Multi-Asset Strategist Nanette Abuhoff Jacobson looks at what’s changed in the markets and what it might mean for investors.
URL References
Related Insights
© Copyright 2025 Wellington Management Company LLP. All rights reserved. WELLINGTON MANAGEMENT ® is a registered service mark of Wellington Group Holdings LLP. For institutional or professional investors only.
Enjoying this content?
Get similar insights delivered straight to your inbox. Simply choose what you’re interested in and we’ll bring you our best research and market perspectives.
Thank you for joining our email preference center.
You’ll soon receive an email with a link to access and update your preferences.